BML-275 5mg 5mg | Purity Not Available
Adooq Bioscience
BML-275 is a cell-permeable pyrazolopyrimidine compound shown to be an AMP-activated protein kinase (AMPK) and fatty acid synthase inhibitor.
More Information Supplier PageBML-275 is a cell-permeable pyrazolopyrimidine compound shown to be an AMP-activated protein kinase (AMPK) and fatty acid synthase inhibitor.
More Information Supplier PageBML-275 is a cell-permeable pyrazolopyrimidine compound shown to be an AMP-activated protein kinase (AMPK) and fatty acid synthase inhibitor.
More Information Supplier PageTCS JNK 5a is a highly selective inhibitor of JNK2 and JNK3 (pIC50 values are 6.7, 6.5,
More Information Supplier PageNF279 is a suramin analog that acts as a highly selective, competitive, and reversible ATP-antagonist of P2X receptor (IC50/KB ~ 1 ??M in smooth muscle).
More Information Supplier PageNecrostatin-1 is an ATP-competitive, allosteric inhibitor of receptor-interacting protein kinase 1 (RIPK1) (EC50 = 182 nM).
More Information Supplier PageMethoctramine hydrate is a selective M2 muscarinic receptor antagonist at nM concentrations
More Information Supplier PageMethoctramine hydrate is a selective M2 muscarinic receptor antagonist at nM concentrations
More Information Supplier PageMethoctramine hydrate is a selective M2 muscarinic receptor antagonist at nM concentrations
More Information Supplier PageW4869 is a cell permeable, selective inhibitor of N-SMase (neutral sphingomyelinase).
More Information Supplier PageW4869 is a cell permeable, selective inhibitor of N-SMase (neutral sphingomyelinase).
More Information Supplier Page